Tag - Uri

Consolidated Water Co Ltd. (Nasdaq:CWCO), SYNNEX Corp. (Nasdaq:SNX) and RXi Pharmaceuticals Corp. (Nasdaq:RXII) are among the biggest percentage gainers in Friday's trading among companies with market capitalizations under $1 billion.

Also included among the results: United Rentals Inc. (Nasdaq:URI), DryShips Inc. (Nasdaq:DRYS), Echelon Corp. (Nasdaq:ELON), Lululemon Athletica Inc. (Nasdaq:LULU), Plantronics Inc. (Nasdaq:PLT) and Young Innovations Inc. (Nasdaq:YDNT).

United Rentals Inc (Nasdaq:URI), i2 Technologies Inc. (Nasdaq:ITWO) and Dynamex Inc. (Nasdaq:DDMX) are among the biggest percentage losers in Thursday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Diamond Foods Inc. (Nasdaq:DMND), AngioDynamics Inc. (Nasdaq:ANGO), Argon St Inc. (Nasdaq:STST), James River Coal Co. (Nasdaq:JRCC), Movado Group Inc. (Nasdaq:MOV) and Arena Resources Inc. (Nasdaq:ARD).

The Russell 2000 (NYSE: IWM) was the only major U.S. index not to partake in the modest rally that followed news of major corporate deals. The small-cap index fell 0.82 points, or 0.10%, to 835.62. The Dow Jones Industrial Average (INDU) added 92.34 points, or 0.67%, to 13,943.42.

With a void of economic news, the bullish sentiment on Wall Street was primarily due to the latest mergers wave.

The Russell 2000 began the day with a healthy rise and briefly touched a level of 842 around 1 p.m. ET before slipping into negative territory shortly before the close.

Houston-based offshore driller GlobalSantaFe Corp. (NYSE: GSF) and city rival Transocean Inc. (NYSE: RIG) agreed to a merger of equals to create a $38 billion combined company. The deal is scheduled to close by the end of 2007.

The Russell 2000 (NYSE: IWM) and the Dow Jones Industrial Average (INDU) are higher on news of earnings and mergers.

At 10:52 a.m. ET the Russell 2000 had added 2.28 points, or 0.27%, to 838.72. The Dow Jones Industrial Average was up 71.37 points, or 0.52%, to 13,922.45.

Pharmaceutical heavyweight Merck & Co., Inc. (NYSE: MRK) reported unexpectedly positive second-quarter results. The Whitehouse Station, N.J.-based company saw its quarterly profit climb 12% due to higher demand for cholesterol-lowering drug Vytorin and cervical-cancer vaccine Gardasil.